Professor Huntington is head of Cancer Immunotherapy at the Biomedicine Discovery Institute, Monash University and the Walter and Eliza Hall Institute of Medical Research. He is an international leader on natural killer (NK) biology and his most notably contributions include; regulatory mechanisms of IL-15 signalling in NK cells, identification of human and murine NK cell differentiation pathways, novel xenograft models to study human NK cell biology and identification of multiple checkpoint in NK cell activation and tumour immunity. Dr Huntington leads a research program aimed at deciphering the regulatory networks that control NK cell development and homeostasis and a drug discovery program using cutting-edge in vivo screens for novel checkpoints in NK cell activation for targeting in cancer immunotherapy.